| P50 | author | Mauro Biffoni | Q37391458 |
| P2093 | author name string | Frati L | |
| | Fattorossi A | |
| | Scambia G | |
| | Nuti M | |
| | Pierelli L | |
| | Rahimi H | |
| | Rughetti A | |
| | Lavitrano M | |
| | Pellicciotta I | |
| | Sabbatucci M | |
| P2860 | cites work | Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product | Q27860841 |
| | Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 |
| | Immunotherapy of cancer with dendritic-cell-based vaccines | Q32066652 |
| | Dendritic cell vaccines for cancer immunotherapy | Q33540299 |
| | Why are dendritic cells central to cancer immunotherapy? | Q33544032 |
| | Specificity of the proteasome and the TAP transporter | Q33632436 |
| | Coordinated events during bacteria-induced DC maturation. | Q33632717 |
| | Degradation of cell proteins and the generation of MHC class I-presented peptides | Q33652524 |
| | Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines | Q33712280 |
| | New directions in liposome gene delivery | Q33721388 |
| | Dendritic cells as natural adjuvants | Q33753580 |
| | Dendritic cells at the end of the millennium | Q33762508 |
| | MUC1 and cancer | Q33778447 |
| | DNA vaccination: transfection and activation of dendritic cells as key events for immunity | Q35834601 |
| | Quantitative analysis of the immunopotency of genetically transfected dendritic cells | Q36640393 |
| | Novel applications of liposomes | Q40850159 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | The epithelial mucin, MUC1, of milk, mammary gland and other tissues | Q40938270 |
| | Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3'-untranslated sequences | Q41228781 |
| | Gene vaccination: plasmid DNA is more than just a blueprint | Q41724485 |
| | Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 |
| | Immunotherapy of cancer with dendritic cell-based vaccines | Q45855885 |
| | Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells | Q45889804 |
| | Genetic vaccination: the advantages of going naked | Q46047034 |
| | Distinct patterns and kinetics of chemokine production regulate dendritic cell function. | Q54093362 |
| | Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture | Q57337285 |
| | Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells | Q70993699 |
| | Biology, biochemistry and immunology of carcinoma-associated mucins | Q73172626 |
| | MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines | Q73343333 |
| | 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence | Q74014815 |
| | Transfected human dendritic cells as cancer vaccines | Q74471551 |
| | The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy | Q77475365 |
| | From antigen presentation to T-cell activation | Q77675898 |
| | Tumor immunology: the glass is half full | Q77769105 |
| P433 | issue | 17 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 1458-1466 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Transfected human dendritic cells to induce antitumor immunity | |
| P478 | volume | 7 | |